---
figid: PMC9367296__cancers-14-03781-g002
pmcid: PMC9367296
image_filename: cancers-14-03781-g002.jpg
figure_link: /pmc/articles/PMC9367296/figure/cancers-14-03781-f002/
number: Figure 2
figure_title: ''
caption: Whole exome sequencing of PDOs (A) Oncoplots depicting the 15 most commonly
  altered genes in The Cancer Genome Atlas (TCGA) cohort of Pancreatic Adenocarcinoma
  (left) compared to the pathogenic and likely pathogenic alterations found by whole
  exome sequencing in PDAC PDOs, modelling the mutational patterns of their tissue
  of origin (right) (B) Visualization of pathway enrichment analysis showing the fraction
  of affected oncogenic signaling pathways in PDAC PDOs (left) compared to the fraction
  of affected oncogenic signaling pathways in TCGA cohort of Pancreatic Adenocarcinoma
  (right).
article_title: 'Combined Systemic Drug Treatment with Proton Therapy: Investigations
  on Patient-Derived Organoids.'
citation: Max Naumann, et al. Cancers (Basel). 2022 Aug;14(15):3781.
year: '2022'

doi: 10.3390/cancers14153781
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- patient-derived organoid
- PDAC
- pancreatic cancer
- radiochemotherapy
- 3D cell culture
- proton irradiation
- translational radiooncology

---
